Thanks to the work of NEI scientists and grantees, we’re constantly learning new information about the causes and treatment of vision disorders. Get the latest updates about their work — along with other news about NEI.
A National Eye Institute (NEI) clinical trial reported today that anew, drug-releasing device was effective in treating cytomegalovirus (CMV) retinitis, a sight-threatening disease that affects one out offour people with AIDS.
After a decade of patient followup, a National Eye Institute (NEI)-supported study reported today that radial keratotomy (RK) remained a reasonably safe and effective technique to improve distance vision.
Most adults with blinding retinitis pigmentosa (RP) should take a daily, 15,000 IU vitamin A supplement, based on results from a large, randomized clinical trial published today in the Archives of Ophthalmology.
The National Eye Institute reported today that current treatmentsfor a common, sight-threatening complication of diabetes have proved95 percent effective in maintaining vision, but 8,000 still go blindeach year from this disease.
Results from two years of patient followup in a randomized clinical trial suggest that argon laser therapy may be a safe and effective alternative to eyedrops as a first treatment for patients with newly diagnosed open-angle glaucoma.
New findings from a nationwide clinical trial supported by theNational Eye Institute (NEI) provide further evidence that laser treatment is highly effective in preventing visual loss from diabetic eye disease.